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Calcium homeostasisAlthough store-operated calcium entry (SOCE) has been implicated in several neurological disorders, the exact
mechanism for its role in traumatic brain injury (TBI) has not been elucidated. In this study, we found that TBI
upregulated the expression of a calcium sensor protein called stromal interactive molecule 2 (STIM2); however,
the levels of its homologue, STIM1, were unaffected. Both STIM1 and STIM2 are crucial components of SOCE, both
in vivo and in vitro. Using shRNA, we discovered that downregulation of STIM2, but not STIM1, signiﬁcantly
improved neuronal survival in both an in vitro and in vivo model of TBI, decreasing neuronal apoptosis, and
preserving neurological function. This neuroprotection was associated with alleviating TBI-induced calcium
overload and preserving mitochondrial function. Additionally, downregulation of STIM2 not only inhibited
Ca2+ release from the endoplasmic reticulum (ER), but also reduced SOCE-mediated Ca2+ inﬂux, decreased
mitochondrial Ca2+, restored mitochondrial morphology and improved mitochondrial function, including
MMPmaintenance, ROS production and ATP synthesis. These results indicate that inhibition of STIM2 can protect
neurons fromTBI by inhibiting calciumoverload and preservingmitochondrial function. This suggests that STIM2
might be an effective interventional target for TBI.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Traumatic brain injury (TBI) is the most common neurological dis-
ease, and as such, has become a signiﬁcant public health problem [1–3].
Primary injuries trigger complex cascades of secondary injury process-
es, which can persist for hours, days, and even months following an in-
jury. Most treatments for TBI are aimed at ameliorating these secondary
insults [4,5]. Disturbance of calcium homeostasis, dysregulation of calci-
um regulatory proteins and/or mitochondrial dysfunction have been
extensively associated with the development of secondary injuries in
neuronal cells after TBI. These secondary injuries can lead to serious
neurological dysfunction and even death [6,7]. Therefore, it is of cruciallateral sclerosis, ALS; Anterior–
e, AUC; Ca2+ release-activated
ventral, DV; Endoplasmic retic-
nase, LDH; Medial–lateral, ML;
ial membrane potential, MMP;
OS; Store-operated calcium
tramethylrhodamine, TMRM;
, TNI; Triﬂuorocabonylcyanide
eling, TUNEL.importance that we investigate the mechanisms of calcium dysregula-
tion in TBI, as well as other neurological conditions.
Store-operated calcium entry (SOCE), which has been extensively
studied in non-excitable cells, is mediated by sensor proteins called
stromal interactive molecules (STIM) and also by Ca2+ release-
activated Ca2+ channels (CACs) [8]. The two known STIM proteins,
STIM1 and STIM2, are distributedmainly on the endoplasmic reticulum
(ER) and are the crucial regulators of SOCE. These proteins function by
sensing the Ca2+ concentration in the ER lumen and mediating extra-
cellular Ca2+ entry to raise cytosolic Ca2+ to reﬁll Ca2+ stores. Numer-
ous studies have demonstrated that SOCE is linked with Ca2+
homeostasis in non-excitable cells [8,9]. Recently, a role for SOCE has
been found in excitable cells as well, particularly in neurons, where
SOCE has been found to regulate synaptic plasticity, neurotransmitter
release, and gene expression [10–13]. Moreover, SOCE has also been im-
plicated in several neurological disorders, including Alzheimer's disease
(AD), Huntington's disease (HD), chronic epilepsy, painful nerve injury
and cerebral ischemia [10,14–16]. Interestingly, the different disorders
seem to be mediated differentially by the STIM family members [17].
For example, Zeiger W. et al. found that STIM1-mediated SOCE reduced
amyloid peptide secretion in AD [18], while Sun S.Y. et al. established
that reduced synaptic STIM2-mediated SOCE causes destabilization of
mature spines in AD [10]. Additionally, STIM2 regulated SOCE in
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nal cell death [14]. However, whether and how STIM1- or STIM2-medi-
ated SOCE has effects in neuronal injury induced by TBI has not been
elucidated.
In this study, we used a scratch model in vitro and a controlled cor-
tex injury (CCI) model in vivo tomimic TBI and explore themechanism
of SOCE in TBI. These results uncovered an important role of STIM2-
mediated SOCE in TBI induced calcium overload andmitochondrial dys-
function. Inhibition of STIM2, but not STIM1, protected neurons from
TBI-induced injury. This neuroprotectionmight partially be due to a de-
crease in TBI-induced calcium overload and reservation dynamics, as
well as a preservation of mitochondria function. Therefore, STIM2 and
STIM2-mediated SOCEmight be an important intervention target in TBI.
2. Materials and methods
2.1. Animals
Mature male (10–12 weeks, 25–28 g) and embryonic (14–15 d)
C57BL/6 mice were obtained from The Experimental Center of Fourth
Military Medical University. The mice were kept at a constant tempera-
ture (approximately 27 °C) in an air-conditioned room and were ex-
posed to a 12-h light/dark cycle. All animal studies were performed in
adherence to the National Institutes of Health Guidelines on the Use of
Laboratory Animals, and were approved by the Fourth Military Medical
University Committee on Animal Care.
2.2. Cortical neuronal culture
Primary cortical neurons were prepared from embryonic 14–15 d
C57BL/6 embryos as previously described [19]. Brieﬂy, cortices of
mouse embryoswere dissected andminced, followed by a 30minute in-
cubation at 37 °C in Ca2+/Mg2+-free HBSS containing 15 U/ml papain
solution (Worthington, Lakewood, NJ, USA) and 0.2 mg/ml DNase I
(Beyotime, Haimen, China). The cellswere re-suspended in a neurobasal
medium supplemented with 2% B27 supplement and 0.5 mM L-
GlutaMax™-I (Gibco, MD, USA) and plated onto poly-L-lysine (Sigma-
Aldrich, MO, USA) coated dishes at a density of 2.5 × 105 cells/cm2.
After 7–10 days of culture, the cells were used for experiments.
2.3. Traumatic injury model on cultured neurons
Traumatic neuronal injury (TNI) was performed according to
Mukhin's method [20], with some modiﬁcations. In brief, traumatic
injury was performed on cultured neurons by using a rotating scribe
injury device, which consisted of a rotating cylinder with ten holes,
steel needles and a permanentmagnet. The cylinder holes are distribut-
ed at the same interval from the center, and these holes allowed the ten
steel needles to freely cross through. A magnet is placed under the cul-
ture dish, which ensured that the steel needles could cling to the cell
layer as the cylinder rotated. After one turn of this device, ten concentric
circular scratches were produced in the neuronal layer with equal dis-
tances (1.5 mm) between the scratches. This model, and its variants,
are highly reproducible and are able to induce severe TNI [21–24].
2.4. Animal models
For in vivo studies, TBI was produced in mice by using a Pinpoint™
Precision Cortical Impactor (PCI3000; Hatteras Instruments, Cary, NC,
USA) in accordancewith previousmethods [25]. For the surgeries, stan-
dard presurgical preparations were followed under sterile conditions.
Brieﬂy,micewere anesthetizedwith isoﬂurane in oxygen (4% for induc-
tion, 2.5% for maintenance) and the animals were placed in the stereo-
taxic frame. After incising the scalp, a craniotomy was performed
using a dental drill with a trephine bit (ø=3mm) on the leftmotor cor-
tex (anterior–posterior (AP)−2mm,medial-lateral (ML) 2.0 mm frombregma). During the procedure, considerable care was taken to avoid
additional injury to the dura. To induce injury, a metal tip (ø =
2.5 mm) was angled vertical to the cortex surface at the center of the
craniotomy. The tip was then lowered to touch the cortex surface, ini-
tially using coarse adjustment and then, as it got closer to the cortex,
ﬁne adjustment, as determined by an electronic continuity sensor.
Once the machine was adjusted properly, the TBI was induced using
the PCI3000 by retracting the tip upward by 2 cm, and then a down
stroke (velocity: 1.5 m/s, deformation depth: 1.5 mm, duration:
120 ms). Immediately after the injury, the wound was tightly sutured
closed and the mice were returned to cages where water and food
were freely available.2.5. Plasmids and lentivirus generation
Optimal STIM1 shRNA (5′-GCA GTA CTA CAA CAT CAA GAA-3′),
STIM2 shRNA (5′-GAC GAA GTA GAC CAC AAG ATT-3′) or scramble
shRNA (5′-UUC UCC GAA CGU GUC ACG U-3′) was cloned into the
lentivirus-based RNAi vector pGCL vector. Its sequence was conﬁrmed
using PCR and sequencing analysis. Lentivirus preparations were pro-
duced by the Shanghai GeneChem, Co. Ltd., China. Primary neurons
were infected by adding lentivirus particles to the neuronal cultures at
an MOI of approximately 30. Forty-eight hours after infection, primary
neurons were used for experiments.2.6. Real-time RT-PCR
After treating the neurons or the mice as indicated for each experi-
ment, total RNA was extracted from neurons or cortexes using a
MiniBEST Universal RNA extraction kit (Takara, Dalian, China) accord-
ing to the manufacturer's protocols. 2 μg of template RNA was used to
synthesize cDNA using a reverse transcription kit (Takara, Dalian,
China). Quantitative RT-PCR was performed using CFX-96 (Bio-Rad,
Los Angeles, CA, USA). Speciﬁcity of the ampliﬁed product was con-
ﬁrmed by examination of dissociation plots and gel electrophoresis.
The following primers were used for real-time PCR: STIM1: forward,
5′-TGA GGC CGT CCG AAA CAT C-3′; reverse, 5′-TCA CTG TTG GGT CAT
GGT AAT TGA G-3′; STIM2: forward, 5′-TCT GTC CCT GAC GCA CTA
CAG AA-3′; reverse, 5′-ACG TGC AGG GTC CCA AAG A-3′;GAPDH: for-
ward, 5′-GGG TCA GAA GGA TTC CTA TG-3′; and reverse, 5′-GGT CTC
AAA CAT GAT CTG GG-3′. Samples were tested in triplicate, and data
from four independent experiments were used for analysis. Relative
gene expression was calculated using the 2−ΔΔCT method [26].2.7. Western blot
Western blots were analyzed as previously described [27]. After
treating the neurons or the mice as indicated for each of the experi-
ments, proteins were extracted from neurons or cortexes using a RIPA
lysis buffer supplemented with protease inhibitors (Roche Applied Bio-
science, Indianapolis, IN, USA). Protein concentration was quantiﬁed
using a BCA protein kit (Thermo Scientiﬁc, USA). Equal amounts of
proteins were loaded on 8–12% SDS-PAGE gels. After electrophoresis,
the proteins were transferred to nitrocellulose membranes. The mem-
braneswere then blockedwith 5% skimmilk and incubated at 4 °C over-
night with the appropriate primary antibody: STIM1, 1:2000; STIM2,
1:1000; β-actin, 1:2000 (CST, Danvers, MA, USA). The blots were then
incubated with horseradish peroxidase-conjugated secondary antibod-
ies (1:20,000, CST, MA, USA), followed by incubationwith a chemilumi-
nescent substrate (Thermo Scientiﬁc, USA) and were detected on ﬁlm.
Western blots for each protein were repeated three times. The optical
densities of the protein bands were calculated using a MiVnt image
analysis system (Bio-Rad, CA, USA), and the results of the three bands
were averaged.
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Lactate dehydrogenase (LDH) is a marker of membrane integrity
damage and an indicator of neuronal apoptosis [28]. To evaluate dam-
aged neurons in these experiments, the release of LDH was quantitated
in the culture medium using a diagnostic kit (Jiancheng Bioengineering
Institute, Nanjing, China) as previously described [29]. An incubation
medium before injury was collected as a pre-injury control. 30 min
after the initial insult, the medium was replaced with a fresh medium
to remove any LDH that was released by neurons damaged during the
initial insult. Twenty-four hours later, this medium was collected for
analysis of LDH.
2.9. Fluorometric TUNEL (TdT-mediated dUTP Nick end-labeling) analysis
TUNEL assays were performed using the DeadEnd™ Fluorometirc
TUNEL system (RocheApplied Bioscience, Indianapolis, IN, USA) accord-
ing to the manufacturer's protocol [29]. Hoechst (Sigma-Aldrich, MO,
USA) staining was performed to assess the total number of cells in
each well. Neurons were observed under a ﬂuorescence microscope
(Leica, Germany) using a standard ﬂuorescein ﬁlter set. Middle regions
between the scratches were analyzed. A nucleus that ﬂuoresced green
from the TUNEL staining was considered to be an apoptotic cell. The
total number of neurons, which ﬂuoresced blue from the Hoechst stain-
ing, was also determined. The ratio of apoptotic cells was calculated as
an apoptotic index (AI = positive apoptotic cells/total cells × 100%),
which was used to determine the apoptotic severity. At least ten high
power ﬁelds were observed per well at 40×.
2.10. Calcium imaging and analysis
To determine cytosolic Ca2+ concentration ([Ca2+]cyt), the primary
neurons were loaded with Fura-red AM (3 μM) (Life Technologies,
Carlsbad, CA, USA) in an HBSS solution supplemented with 20 mM D-
glucose and 10 mM HEPES (HBSS) (Gibco, MD, USA) for 45 min, and
equilibrated for 30 min in the dark. To assess ER Ca2+ concentration
([Ca2+]ER) andmitochondrial Ca2+ concentration ([Ca2+]Mito), neurons
were co-transfected with the plasmids of pCMV R-CEPIA1er and pCMV
CEPIA2mt (Addgene, Cambridge, MA) using Lipofectamine LTX-plus
(Invitrogen, CA, USA). These plasmids are new calcium-measuring
organelle-entrapped protein indicators [30]. All images were captured
with a confocal laser scanning microscope (FV10i, Olympus, Tokyo,
Japan), and the ﬂuorescence changes were determined in an XYT-
plane fashion at the following excitation/emission wavelengths (nm):
Fura-red AM (494/505–550), pCMV CEPIA2mt (473/520), and pCMV
R-CEPIA1er (559/572). The objective lens, work stage and perfusion
lineswere heated to 37 °C. Signals fromdifferent groupswere compared
using identical settings for laser power and detector sensitivity for each
separate experiment. For detecting SOCE, the buffer was changed with
Ca2+-free HBSS with 2 μM thapsigargin (TG) for 30min. After this incu-
bation, 2 mM Ca2+ was added that contained a Ca2+ channel inhibitor
cocktail (10 μM CNQX, 10 μMAP5, and 50 μM nifedipine), which blocks
any Ca2+ inﬂux from ionotropic glutamate receptors (NMDA and
AMPA) and L-type VDCCs [10,12]. Ca2+-insensitive ﬂuorescence was
subtracted from each wavelength before calculations to normalize ﬂuo-
rescence values. The values were then plotted against time and shown
as F/F0. The area under the curve (AUC), peak ﬂuorescence and peak
timewere assessed for each plot. For each experiment, at least four cul-
tured neuron coverslips prepared from three or more mice cortexes
were analyzed.
2.11. Detection of mitochondrial reactive oxygen species [ROS]mito and
mitochondrial membrane potential (MMP)
In order to detect [ROS]mito, the primary neurons were
transfected with the plasmid pMitotimer (Addgene, Cambridge, MA)using Lipofectamine LTX-plus (Invitrogen, CA, USA). pMitotimer is a re-
cently engineered reporter gene used to assess mitochondrial content,
structure, stress, and damage [31]. In order to detect MMP, neurons
were loaded with tetramethylrhodamine (TMRM; 20 nM) in the same
manner as with Fura-red loading. The neurons were then washed and
imaged in the loading buffer. Images were acquired using a confocal
laser scanning microscope at the following excitation/emission wave-
lengths (nm): pMitotimer green (488/518) and red (543/572) and
TMRM (543/560). For the ﬂuorescence detection of MMP, the neurons
were subjected to TNI using the scratch method as described above
and then treated with 1 μM triﬂuorocabonylcyanide phenyhydrazone
(FCCP; a mitochondria uncoupler) to normalize the baseline level.
Images were acquired with Olympus confocal software F10V-ASW
and analyzed using ImageJ (National Institutes of Health). The level of
[ROS]mito was shown as the ratio of red/green as previously described
[31]. MMP was examined by the formula: (Ft− FFccp) / ((Ft− FFccp) in
uninjured group) × 100. (Ft: average ﬂuorescence intensities after
TNI; FFccp: average ﬂuorescence intensities after addition of FCCP).
2.12. Stereotaxic injection of lentivirus
The lentiviral vectors were delivered into the mice cortex for the
in vivo studies using a stereotaxic cortical injection as described previ-
ously [32,33] with some modiﬁcations. Three cortical injections were
performed in the right hemisphere (ipsilateral to the lesion) as follows:
point 1 (AP 0 mm, ML 2 mm from the bregma; dorsal–ventral (DV)
1.5 mm from the skull); point 2 (AP−2 mm, ML 4 mm from the breg-
ma, DV 1.5mm from the skull); point 3 (AP−4mm,ML 2mm from the
bregma, DV 1.5 mm from the skull). All the target points were in the
right hemisphere (ipsilateral to the lesion). Each injection contained
1.5 μl of lentivirus suspension (1 ∗ 109 TU/ml) at a rate of 0.2 μl/min
and with an additional needle retaining time for 10 min. Seven days
after injection of lentivirus, mice were subjected to TBI using the CCI
method as described above.
2.13. Analysis of contusion size
After deeply anesthetizing the mice, the animals were perfused with
pre-cold PBS plus 0.01% heparin followed by 4% paraformaldehyde in
PBS transcardially. The brains were then removed and post-ﬁxed in 4%
paraformaldehyde overnight at 4 °C. The brainswere then cryoprotected
in 30% sucrose for twenty-four hours before cutting coronal slices
(20 μm) with a freezing microtome (Leica, Wetzlar, Germany) at
400 μm intervals throughout the brain hemispheres. Four sections
were obtained at each interval, mounted onto a glass slide, and stained
with 0.1% cresyl violet. Histological lesion areas were quantiﬁed with
ImageJ analysis program, and lesion areaswere then integrated to obtain
total lesion volume in cubic millimeters.
2.14. Rotarod test
The standard rotarod test was performed to evaluate the neurologi-
cal impairment, as it has been extensively used to assess rodent brain
trauma with high effectivity and reliability [5,34]. Brieﬂy, the rotarod
consists of a tiltable ﬁve-lane digital-control platform and a motorized
cylinder controlled by software which accelerates the platform linearly
until the animal falls off (Ugo, Varese, Italy). Mice were trained on the
rotarod platform at a speed of 18 rpm for 4 days in the acceleration
mode (0–18 rpm/90 s) prior to CCI. Every mouse was tested for three
trials with an internal of 10min between each trial. Pre-injury baselines
were obtained on the rotarod 1 h before CCI. Scores were measured as
the time successfully spent running on the rotarod. After the injury,
each mouse was measured at three time-points (1, 3, and 5 d after
CCI). The scoreswere normalized to the scores of the shamgroup before
CCI.
Fig. 1. Differential expression of STIM proteins after experimental TBI in vitro and in vivo. The STIM proteins in primary cultured cortex neuron were detected after TNI at different timepoints by qRT-PCR andWestern blot. Relative expressions of
STIM1mRNA (A) and protein (B)were not signiﬁcantly altered after TBI. However, relative expressions of STIM2mRNA (C) and protein (D)were increased. The STIMproteins in the brain cortex ipsilateral to CCIwere evaluated after experimental TBI
for different timepoints by qRT-PCR andWestern blot. Sham-injured mice were used as a control. Relative expressions of STIM1mRNA (E), protein (F) were not changed signiﬁcantly. However, relative expressions of STIM2mRNA (H) and protein
(I) were increased in the injured cortex. Data are means ± SEM; *, p b 0.05 vs. uninjured group, in vitro, n = 4; *, p b 0.05 vs. sham group, and in vivo, n = 7 for each group.
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All of the experiments were performed at least three times. The
values were expressed as a mean ± SEM, and analyzed by ANOVA
followed by Bonferroni's multiple comparisons or unpaired t-test with
SPSS 22.0 statistical software (IBM, Armonk, New York, USA). p b 0.05
was considered to be statistically signiﬁcant.
3. Results
3.1. Upregulation of STIM2 expression, but not STIM1, induced by TBI
in vitro and in vivo
STIM1 and STIM2 have crucial, but different roles in regulating SOCE.
To examine the effect of TBI on STIM expression, a traumatic neuronal
injury (TNI) was induced in cultured primary mice neurons using a
scratch method, and changes in STIM1 and STIM2 mRNA expression
and protein levels were determined using qRT-PCR and Western blot.
The mRNA and protein from these cells were harvested at 1, 3, 6, 12,
and 24 h post-TNI. Both the mRNA (Fig. 1C) and protein levels (Fig.
1D) of STIM2 were signiﬁcantly elevated at 1, 3, 6, and 12 h post-TNI.
STIM1 mRNA and protein levels were not affected (Fig. 1A and B).
In order to assess these results in vivo, TBIwas induced inmice using
a controlled cortical injury (CCI) model. The cortexes ipsilateral to theFig. 2.Downregulation of STIM2 improves neuronal survival after TNI in vitro. After infection of
assessed for both themRNA (A) and protein levels (B and C). After infectionwith lentivirus part
(D), and the neuron apoptosis was detected by TUNEL staining (E: red, TUNEL-positive; blue, Ho
not subjected to lentiviral infection or injury. Data are means ± SEM; *, p b 0.05 vs. normal orinjury were used for qRT-PCR and Western blot analyses. In agreement
with the in vitro data, the mice also had upregulated expression of
STIM2 mRNA (Fig. 1H) and elevated protein levels (Fig. 1I). The mRNA
was upregulated at 3, 6, 12, and 24 h post-CCI (Fig. 1H) and the protein
levels were increased at 6, 12, 24 h and 3 d post-CCI (Fig. 1, I). Again, as
with the in vitro data, STIM1 levels were unchanged (Fig. 1E, F). There-
fore, we conclude that TBI induces the upregulation of STIM2 expres-
sion, but not STIM1, both in vitro and in vivo.
3.2. Knockdown of STIM2 protects against TNI-induced neuronal injury
In order to further elucidate the role of STIM1 and STIM2 in TNI-
induced neuronal injury, we constructed STIM1 and STIM2 lentivirus-
based RNAi vectors to downregulate the expression levels of both
genes independently. Downregulation of both the mRNA and protein
for both genes was conﬁrmed using real-time RT-PCR and Western
blot analyses. As shown in Fig. 2A, transfection of either STIM1-shRNA
or STIM2-shRNA for 72 h signiﬁcantly downregulated mRNA level by
approximately 80% compared with those of normal and the Scr-shRNA
groups, but had no effects on expression of either STIM gene, indicating
the speciﬁcity of the shRNA. Similarly, protein levelswere also knocked-
down as determined by Western blot assay (Fig. 2B and C). Consistent
with previous studies, our scratching model of TNI signiﬁcantly in-
creased LDH release and the apoptosis index in un-transfected (dataScr-shRNA, STIM1-shRNA or STIM2-shRNA for 48 h, the efﬁciency of downregulation was
icle for 72 h and subjected to TNI for 24 h, the neuronal viability was assessed by LDH assay
echst). The apoptotic indexwas then calculated (E). Neurons in the uninjured groupwere
uninjured group, and **, p b 0.05 vs. Scr-shRNA + TNI group, n = 4. Scale bars = 100 μm.
2407W. Rao et al. / Biochimica et Biophysica Acta 1852 (2015) 2402–2413not shown) and Scr-shRNA treated cells (Fig. 2D, columns 3 and 4, and
Fig. 2E and F, column 2 for both). Interestingly, downregulation of
STIM2 with shRNA signiﬁcantly alleviated TNI-induced neuron injury,
including decreasing LDH release (Fig. 2D, columns 7 and 8) and reduc-
ing the apoptosis index (Fig. 2E and F, columns 4 for both). Downregu-
lation of STIM1 seemed to slightly alleviate TNI-induced neuronal
injury, but these results were not statistically signiﬁcant (Fig. 2D,
columns 5 and 6, and Fig E and F, column 3 for both). Cells that were
not injured were included as controls (Fig. 2D, columns 1 and 2, and
Fig. 2E and F, column 1 for both). Non-transfected cells subjected to
TNI were not statistically different from cells transfected with Scr-
shRNA, so they were omitted from the graphs. Taken together, these re-
sults indicate that downregulation of STIM2 attenuated TNI-induced
neuronal injury.
3.3. Knockdown of STIM2 alleviated the calcium overload induced by TNI
Accumulating evidence has demonstrated that STIM1 and STIM2
have crucial roles in neuronal calcium homeostasis. Moreover, calcium
disturbance is one important injurymechanism of TBI. Therefore, to un-
derstand the impact of STIM1 or STIM2 on calcium dynamics, we used
shRNA knockdown of both STIM genes in cultured primary mice cortex
neurons, and measured intracellular calcium dynamics using live-cell
imaging with the ﬂuorescent dye Fura-red. As shown in Fig. 3A, com-
pared with that of uninjured normal group, TNI treatment signiﬁcantly
increased intracellular calcium levels in the Scr-shRNA transfected cells
as indicated by an increased area under the curve (AUC) (Fig. 3B) and
peak F/F0 (Fig. 3C). Compared with Scr-shRNA group, STIM1 and
STIM2 shRNA signiﬁcantly reduced AUC (Fig. 3B); however, STIM2
downregulation also signiﬁcantly decreased the peak F/F0 (Fig. 3C)Fig. 3. Effects of STIM knockdown on intracellular Ca2+ concentration ([Ca2+]cyt) after TNI. The
particles for 48 h, the cortical neurons were subjected to TNI and the [Ca2+]cyt was measured up
(C) and peak time (D). 40–50 cells were analyzed in each experiment. Neurons in the uninju
means ± SEM. *, p b 0.05 vs. uninjured group, **, p b 0.05 vs. Scr-shRNA + TNI group, #p b 0.0and peak time (Fig. 3D). From these results, we conclude that while
both STIM1 and STIM2 affected the TNI-induced intracellular calcium
disturbance, STIM2 might play the primary roles in cortical neurons.
3.4. Knockdown of STIM2 alleviated calcium release and entry induced by
TNI
In previous studies, we have found that both calcium release and
calcium entry affect neuronal injury. Additionally, SOCE is a dynamic
calcium regulatingmechanism for calcium release and entry. Therefore,
we wanted to further evaluate the effects of SOCE on TNI-induced calci-
um disturbance. Consistent with previous studies of SOCE in neurons,
treatment of TG induced a signiﬁcant calcium release in the absence of
extracellular Ca2+, followed by calcium entry immediately after resto-
ration of extracellular Ca2+ in uninjured neurons (Fig. 4A and B). This
suggests the existence of SOCE in cortex neurons. After TNI treatment,
calcium release was signiﬁcantly delayed as compared with uninjured
controls (Fig. 4A and E), despite similar calcium entry (Fig. 4B, F, G
and H). To reduce other channels' effects on calcium entry and evaluate
the role of SOCE in TNI, a Ca2+ channel inhibitor cocktail (10 μM CNQX,
10 μMAP5, and 50 μMnifedipine) was added to themedia. This cocktail
inhibits diverse calcium processes involved in TNI, including NMDAR
and AMPAR. Compared with those of TNI group, the AUC (Fig. 4F,
column 3) and peak F/F0 (Fig. 4G, column 3)of TNI-induced Ca2+
entry were signiﬁcantly reduced in Scr-shRNA + TNI group after cock-
tail application (Fig. 4B), demonstrating that other Ca2+ channels
were also involved in the TNI-induced Ca2+ disturbance. Downregula-
tion of STIM1 signiﬁcantly delayed the peak time (Fig. 4E, column
4) of TNI-induced Ca2+ release, but did not affect AUC (Fig. 4C, column
4) and peak F/F0 (Fig. 4D, column 4) when compared with those of the[Ca2+]cyt was determined by the calcium indicator Fura-red. After infection with lentivirus
to 3 h after injury, shown as time–series curve graph (A), area under curve (B), peak F/F0
red group were not subjected to lentiviral infection or injury. Data were represented as
5 vs. STIM1-shRNA + TNI group.
Fig. 4. Effects of STIM knockdown on Ca2+ release and SOCE after TNI. After infection with lentivirus for 48 h, the cells were loaded with Fura-red and baseline levels were recorded. The
neuronswere then insulted by TNI or 2 μMTG to release Ca2+ from calcium stores (black dotted line) using Ca2+-free buffer. The cocktail was subsequently added into the buffer (gray full
line) for 5min in the cocktail-included group and the buffer was semi-refreshed with Ca2+ buffering (black full line) supplementedwith cocktail or not according to experimental group.
Ca2+ releasewas shownas time–series curve (A) and assessed as area under curve (C), peak F/F0 (D) and peak time (E). Ca2+ entrywas shown as time–series curve (B, aminiature version
of ﬁgure A is included in the dotted box for reference) and assessed as area under curve (F), peak F/F0 (G) and peak time (H). 40–50 cells were analyzed in each experiment. Data were
represented as means ± SEM. *p b 0.05 vs. uninjured + TG group, #p b 0.05 vs. TNI group, **p b 0.05 vs. Scr-shRNA + TNI group, ##p b 0.05 vs. STIM1-shRNA + TNI group.
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cantly reduced both AUC (Fig. 4C, column 5) and peak F/F0 (Fig. 4D,
column 5), as well as delaying the peak time (Fig. 4E, column 5) of
TNI-induced Ca2+ release as compared with the Scr-shRNA group. Fur-
ther, calcium entry was also evaluated in cells with STIM1 knocked-
down, as comparedwith the scrambled controls (Fig. 4B). STIM1 knock-
down decreased the peak time (Fig. 4H, column 4) of Ca2+ entry; but,
the AUC (Fig. 4F, column 4) and the peak F/F0 (Fig. 4G, column 5) was
not affected. Downregulation of STIM2 signiﬁcantly decreased the AUC
(Fig. 4F, column 5) and peak F/F0 (Fig. 4G, column 5), and delayed
the peak time (Fig. 4H, column 5) compared with that of Scr-shRNA
TNI and STIM1–shRNA group. Taken together, these results further
demonstrate that STIM2 might be a key mediator of TBI-induced calci-
um release and entry.
3.5. Knockdown of STIM2 alleviatedmitochondrial calciumoverload and ER
calcium release induced by TNI
After determining the role of STIM2 in TNI induced calcium release
and entry, we further investigated the change of mitochondrial buffer-
ing and ER calcium release, both of which are important components
of cellular calciumhomeostasis.We used recently developed genetically
encoded Ca2+ indicators (pCMV R-CEPIA1er and pCMV CEPIA2mt),
which can be utilized for intraorganellar Ca2+ imaging. This technique
provides the unique advantage of simultaneously detecting mitochon-
drial and ER Ca2+ levels with high sensitivity. As shown in Fig. 5A and
B, mitochondrial calcium buffering was not signiﬁcantly different
among any of the groups tested in the absence of extracellular calcium.
However, downregulating STIM2 expression signiﬁcantly decreased ER
calcium release as compared with that of Scr-shRNA TNI group (Fig. 5C
and D). Although STIM1 knockdown also reduced ER calcium release ascompared with the Scr-shRNA TNI group, this difference was not statis-
tically signiﬁcant (Fig. 5C and D). Once extracellular calcium was re-
stored, mitochondrial calcium levels immediately increased in the
scrambled control group by 2.51 fold over the normal level. Interesting-
ly, downregulation of STIM2, but not STIM1, attenuated the increase of
mitochondrial calcium levels, such that it was only 1.42 fold over of nor-
mal level (Fig. 5A and C). A similar effect was seen in the ER, however,
there only was a slight and instant increase of ER calcium after extracel-
lular restoration (Fig. 5C). Additionally, treatment of FCCP, which was a
mitochondria uncoupler, and has shown neuroprotective roles in TBI,
reduced TNI induced mitochondrial calcium overload (Fig. 5A), but
had no signiﬁcant effect on ER calcium (Fig. 5C). These results demon-
strated that downregulation of STIM2 alleviated TNI inducedmitochon-
drial calcium overload and ER calcium release.
3.6. Knockdown of STIM2 improved the mitochondrial dynamics and
dysfunction induced by TNI
After conﬁrming the effects of STIM2 downregulation on cellular
calcium, we further studied whether the downregulation of STIM2
would affect mitochondrial function, as mitochondrial dysfunction
plays a central role in TBI. To determine changes in mitochondrial mor-
phology, ROS production, and mitochondrial damage, primary cortex
neurons were ﬁrst infected with a lentivirus vector at division (DIV) 4,
followed by transfection with a pMitoTimer Reporter Gene at DIV6 as
previously described. The cells were then subjected to TNI at DIV8.
Twenty-four hours after injury, TNI induced signiﬁcant mitochondrial
fragmentation (Fig. 6A and B) and ROS overproduction (Fig. 6 A and
C). Downregulation of STIM2 attenuated mitochondrial fragmentation
(Fig. 6A and B) and ROS overproduction (Fig. 6A and C) as compared
with those of the Scr-shRNA group. This suggests that STIM2 mediated
Fig. 5. Effects of STIM knockdown onmitochondrial Ca2+ uptake and ER Ca2+ release after TNI. After infection with lentivirus for 48 h, neurons were co-transfected with the plasmids of
pCMVCEPIA2mt (green,Mito Ca2+ indicator) and pCMVR-CEPIA1er (red, ER Ca2+ indicator) for 24 h, andmounted on a confocal laser scanningmicroscope for Ca2+ imaging.Mitochon-
drial Ca2+was analyzed as time–series curve graph (A) and peak F/F0 (B, Ca2+-free; C, Ca2+-addition). ERCa2+was analyzed as time–series curve graph (D) and peak F/F0 (E, Ca2+-free; F,
Ca2+-addition). 30–40 neuronswere analyzed in each experiment. Datawere represented asmeans± SEM. *p b 0.05 vs. Scr-shRNA+TNI group, #p b 0.05 vs. STIM1-shRNA+TNI group.
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production in TBI. Furthermore, TNI triggered a signiﬁcant loss of
MMP (Fig. 6 D) and a reduction of ATP synthesis (Fig. 6E) in Scr-
shRNA group. STIM2 downregulation signiﬁcantly attenuated both the
loss of MMP (Fig. 6D) and the decrease in ATP synthesis (Fig. 6E).
STIM-1 knockdown slightly improved mitochondrial dysfunction as
compared with scramble controls, but again, this result was not signiﬁ-
cant. Taken together, these data indicate that STIM2 downregulation
might have a protective role in TBI-induced mitochondrial dysfunction,
including protecting against mitochondrial fragmentation, ROS over-
production, loss of MMP and impairment of ATP synthesis.
3.7. Knockdown of STIM2 reduced brain damage and improved sensorimo-
tor deﬁcit recovery after TBI
To further assess the role of STIM2 in secondary brain injury after
trauma, we knocked down the expression of STIM2 in vivo, using intra-
cranial injection of STIM2-shRNA lentiviral vectors into the cortex of
mice. Seven days after the injection of the shRNA, mice were subjected
to TBI, using a controlled cortical injury (CCI) as before. Sham-operated
animals that did not receive TBI were included as controls. As compared
with Scr-shRNA group, STIM2-shRNA injected mice have a decreased
apoptosis rate (Fig. 7A and B) and brain injury volume (Fig. 7C), sug-
gesting an important role of STIM2 in promoting secondary brain injury,
although this neuroprotection was not as profound as in the primary
neuronal cultures, which might due to the limited efﬁcacy of lentivirus
infection in vivo. Behavioral deﬁcits were also assessed using a standard
rotarod test as before. Mice injected with the scrambled control had
signiﬁcant impairments in sensorimotor functions compared with
sham group. These animals gradually recovered up to 45% of their
sensorimotor function by day 3 post-injury (Fig. 7D). STIM2 knockdownsigniﬁcantly improved the sensorimotor function recovery after TBI
(Fig. 7D), highlighting the critical role of STIM2 in promoting behavioral
deﬁcits, as well as apoptosis rate and injury volume, after TBI.
4. Discussion
The present studies have established a novel role of SOCE in TBI,
affecting intracellular calcium homeostasis, and altering cytoplasmic,
mitochondrial and ER calcium dynamics, as well as mitochondrial
function. In addition to this, we found that TBI upregulated the expres-
sion of STIM2, without affecting STIM1 expression. Using knockdown
studies, we demonstrated that the downregulation of STIM2 alleviated
TBI-induced ER calcium release and calcium entry, both of which
might contribute to TNI-induced neuronal calcium overload, and also
decreased themitochondrial calcium level. Furthermore, mitochondrial
dysfunction triggered by TNI was improved after STIM2 knockdown.
Therefore, given the calciumhomeostasis disturbance andmitochondri-
al dysfunction are both crucial pathogenic mechanisms of secondary
injury of TBI, different therapeutic drugs or strategies which target
STIM2 or STIM2-mediated SOCEmight contribute to develop new ther-
apeutic protocols of TBI.
SOCE, a crucial regulating mechanism of cellular calcium homeosta-
sis, was dynamically regulated by STIM proteins, namely STIM1 and
STIM2 [8]. In the present study, STIM2, but not STIM1, was signiﬁcantly
upregulated in both a mechanical scratch model in vitro and a CCI
model in vivo. Previous studies have demonstrated that the dysregula-
tion of STIM expression was involved in other neurological diseases
[10,15,35,36]. For example, no alteration of STIM1 was reported in sen-
sory neurons of a painful nerve injury model or a model of Parkinson's
disease (PD) [16,37], which is consistent with our studies. However,
Li Y et al.'s study using a brain diffuse axon injury model did suggest
Fig. 6.Effects of STIMknockdownonmitochondrialmorphology anddysfunction after TNI. Neuronswere infectedwith lentivirus particles for 48 h. To visualizemitochondrialmorphology
and oxidative stress level, neurons were transfected with pMitotimer 24 h before TNI treatment. Representative confocal images of mitochondrial morphology and oxidative stress
(A, green, non-oxidative levels; red, oxidative levels; the lowest images were the ampliﬁcation of area in dotted box) and quantiﬁcation of mitochondrial length (B) and mitochondrial
oxidative levels (C) in pMitotimer positively transfected primary mouse cortex neurons. Scale bar, 30 μm in upper images, and 10 μm in the lowest images. 40–50 neurons were analyzed
per group.Measurements ofMMP (D) andATP (E) are shown. 250–270neuronswere analyzedper group. Datawere represented asmeans±SEM from four experiments. *p b 0.05 vs. Scr-
shRNA + TNI group, #p b 0.05 vs. STIM1-shRNA + TNI group.
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model of chronic epilepsy, both STIM1 and STIM2 are both increased
in the hippocampus [15], while in an Alzheimer's disease (AD) model,
Sun Suya et al. found reduced STIM2 expression [10]. Taken together,
these studies suggest that different cell distribution and microenviron-
ments found in these different models, as well as in different brain re-
gions, when coupled with the diverse subcellular localization of STIM
proteins allow for differential regulation of the STIMproteins. These dif-
ferences also allow STIM proteins to play different roles in neurologicaldiseases. Therefore,more attention should be paid to explore the under-
lying mechanisms of the STIM proteins.
Currently, the role of STIM proteins in nervous system is intensively
being investigated, not only in pathological conditions, but also in
physiological conditions. Physiologically, native STIM-mediated SOCE
is involved in maintaining cellular calcium homeostasis [13,39,40], reg-
ulating gene expression and proliferation [11,12], affecting growth cone
turning [41] and synaptic plasticity [42,43]. Unquestionably, abnormal
STIM-mediated SOCE also participates in pathogenic mechanism of
Fig. 7. Downregulation of STIM2 reduced neuronal apoptosis, decreased brain lesion volume and improved neurological deﬁcit recovery after TBI. Mice were injected with lentivirus
particle, followed by CCI. The CCI injury zone (gray box) and microscope imaging zone (red dotted box) were shown in the sketch map of a coronal section of the mice brain (A). 3 d
after TBI, the apoptotic rate was assessed (A and B). n= 3 for each group, scale bar= 100 μm. Lesion volumewasmeasured 7 d post-TBI by cresyl violet staining (C). Neurological deﬁcits
were assessed using a standard rotarod test (D). n = 5 (sham group), 5 (Scr-shRNA group), and 6 (STIM2-shRNA group). *p b 0.05 vs. Scr-shRNA + CCI group.
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amyotrophic lateral sclerosis (ALS) [46]. In the current study, we also
found that downregulation of STIM2, but not STIM1, alleviated TBI-
induced neuron injury, in agreement with a previous study of cerebral
ischemia [14]. The functional differences between STIM1 and STIM2
have also been found in different conditions, including in several disease
models [14,17,47]. For example, the downregulation of STIM1 alleviated
neuronal injury from oxidative stress [48,49] and ischemia injury [47],
while decreased STIM2 expression or impaired SOCE were observed in
AD [10] and PD [37]. Additionally, restoration of SOCE rescued mush-
room spine loss [10] and increased neuron survival in a model of PD
[37].
Previous studies found that the relative expression levels of STIM
proteins varied by cell type, and even varied in neurons of different
brain regions [14,50]. It is also known that STIM2 has a lower sensitivity
to ER calcium stores and slower oligomerization rate than STIM1 [51].
These differences cause different SOCE signals between the two pro-
teins, which leads to diverse downstream signaling. The differences be-
tween STIM1 and STIM2 expression patterns might explain the
differences found in diseases related to these two proteins. Additionally,
STIM1 and STIM2 have recently been implicated as intracellular signal-
ing regulatingmolecules [52]. Therefore, STIM1 and STIM2may activate
different downstream signaling cascades, triggering different molecularevents, which may also explain differences between the roles of these
two proteins. As very little is currently understood about the role of
the STIMproteins in signaling events,much still needs to be done to elu-
cidate about the role and difference of STIM1 and STIM2. In this paper,
we have helped further understand the role of STIM2 by demonstrating
that STIM2-mediated SOCE had a pathological role in TBI, and more
efforts should pay to clarify the difference between STIM1 and STIM2
in TBI and other diseases.
Calcium homeostasis and signaling is extensively involved in neuro-
logical diseases, including TBI. Our results determined that downregula-
tion of STIM2 reduced TBI-induced intracellular calcium overload, ER
calcium release and mitochondrial calcium uptake. Previous studies in-
dicated that both calcium inﬂux from ionotropic glutamate receptor
(NMDA) activation and calcium release from the ER frommetabotropic
glutamate receptor (mGluR1) activation contributed to secondary inju-
ry of TBI [19,53,54]. Additionally, our studies found that Ca2+ inﬂux
occurred through other calcium channels after TNI, and that after
STIM2 downregulation, TBI-induced calcium release was attenuated.
This phenomenon might due to decreasing ER calcium stores as the
result of downregulation of the reﬁlling mechanism. Furthermore, de-
creasing TBI-induced SOCE was also observed after STIM2 knockdown.
Both decreasing calcium ER release and reducing SOCEmight have con-
tributed to attenuating TNI-induced cell calcium overload after STIM2
2412 W. Rao et al. / Biochimica et Biophysica Acta 1852 (2015) 2402–2413knockdown. These results are in agreement with a previous study in
cerebellar Purkinje neurons, which established that SOCE controlled
mGluR1 related Ca2+ signaling by affecting ER calcium [13]. Together,
these data might demonstrate that STIM2 is an essential regulator of
SOCE in cortex neurons.
Accumulating evidence has indicated that mitochondrial dysfunc-
tion plays an important role in TBI. In this study, we established a
novel mechanistic linker among SOCE, mitochondrial dynamics and
dysfunction in cortex neurons. Our study found that experimental TNI
elicited mitochondrial fragmentation, ROS overproduction, MMP loss
and ATP metabolism dysfunction in consistency with the study on glu-
tamate excitotoxicity [55]. Downregulation of STIM2 rescuedmitochon-
drial fragmentation, reduced ROS level and MMP loss, and ﬁnally
improved ATP metabolism dysfunction. Normal mitochondrial mor-
phology highly affects mitochondrial function (like ROS production,
MMP maintaining and ATP synthetizing), which depended on native
mitochondrial ﬁssion/fusion dynamics [56]. MFN2, a crucial regulating
protein of mitochondrial fusion, is associated with TBI and regulates
STIM1 trafﬁcking and SOCE [57–59]. Wang et al. demonstrated that
MFN2was involved in glutamate-inducedmitochondrial fragmentation
and dysfunction via calpain-mediatedMFN2 degradation, a crucial inju-
ry mechanism in secondary injury of TBI [55]. Consistent with this, our
study also observed that MFN2 expression was downregulated 12 h
after TBI (data not shown). Recent evidence found that SOCE regulated
protein expression and degradation in neurons [11,12]. Therefore, the
effects of STIM2 onmitochondrial dynamicsmight be regulated through
MFN2; however, the exactmechanisms need to be further clariﬁed. Ad-
ditionally mitochondrial Ca2+ also plays a critical physiological role in
regulatingmitochondrial dynamics, cellular energymetabolism and sig-
naling, and its overload contributes to various pathological conditions
including neuronal apoptotic death in neurological diseases. Some stud-
ies have found that SOCE affected mitochondrial Ca2+ uptake [57], and
extensive communication and crosstalk existed among intracellular, ER
and mitochondrial Ca2+. As our study also found that STIM2 knock-
down led to a signiﬁcant inhibition of TNI-induced mitochondrial over-
load, it is also possible that knocking down or inhibiting STIM2 might
attenuate TNI-induced mitochondrial fragmentation and dysfunction
by regulating Ca2+ signaling.
In conclusion, this study provided experimental evidences that
STIM2 is involved in TBI-induced calcium homeostasis disturbance
and mitochondrial dysfunction, promoting secondary brain injury.
Downregulation of STIM2 showed a neuroprotective role in TBI. These
results might contribute to the further understanding of the pathophys-
iological mechanisms and develop new therapeutic strategies. The two
main aspects about STIM mediated SOCE that are most pressing to un-
derstand include: (1) the exact mechanisms in the difference roles of
STIM1 and STIM2 in TBI; and (2) given emerging role of SOCE in regulat-
ing signaling pathways [11–13], determining other potential signaling
or partner molecules which are involved in STIM2-induced neuronal
injury.
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